Barzolvolimab: A New Hope for Inflammatory Diseases? Barzolvolimab, a recently identified therapeutic molecule, is generating substantial excitement within the scientific field. This innovative antibody functions as a effective inhibitor of interleukin- 17F, a crucial driver in the development of various autoimmune conditions, including IBD. Preli